What insurance companies actually cover for GLP-1 drugs

Most insurance plans do cover GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound, Mounjaro), but whether yours will depends on three things: what the drug is prescribed for, what your specific plan allows, and whether you meet your plan's requirements before they'll pay. Insurance companies distinguish between using these drugs for type 2 diabetes — which most plans cover — and using them for weight loss — which many plans do not, or cover only under strict conditions.

The coverage difference matters financially. A month's supply of semaglutide can cost $900 to $1,500 without insurance. With insurance, your cost is typically a copay of $25 to $250 per month, depending on your plan and whether the drug is on your plan's formulary (the list of drugs your insurance will pay for). Some plans cover it with no copay at all.

Your insurance company will not tell you whether they cover a drug until your doctor submits a prescription. That submission triggers a process called prior authorization, where the insurer reviews whether the prescription meets their rules. This process takes three to seven business days, and your pharmacy cannot fill the prescription until it is approved.

Key Takeaways

  • Insurance covers GLP-1 drugs for type 2 diabetes much more consistently than for weight loss, so the reason your doctor prescribes it determines whether your plan will pay.
  • Your insurance company requires prior authorization before filling any GLP-1 prescription, which means your doctor's office must submit paperwork and wait for approval — this is not automatic.
  • Many plans require you to try and fail on cheaper diabetes or weight-loss drugs first, a process called step therapy, before they will cover a GLP-1 medication.
  • If your plan denies coverage, you can ask your doctor to appeal the decision or request an exception, which sometimes succeeds if your medical situation is unusual.
  • The copay you pay depends on which tier your plan places the drug on — tier 1 is cheapest, and GLP-1 drugs are often on tier 3 or 4, the most expensive categories.

How to learn about your specific plan covers GLP-1 drugs

Call the customer service number on the back of your insurance card and ask directly: "Does my plan cover semaglutide or tirzepatide for [diabetes/weight loss]?" Have your member ID and group number ready. The representative will tell you whether the drug is on your formulary, what tier it is on, and what your copay would be. Write down the name of the representative and the date you called — you will need this if there is a dispute later.

If your plan covers the drug, ask the second question: "Does my plan require prior authorization or step therapy?" Prior authorization means your doctor has to get approval before the pharmacy fills the prescription. Step therapy means your insurance will only pay for the GLP-1 drug if you have already tried and failed on other drugs first. Both slow down the process, but knowing this in advance lets your doctor prepare the paperwork.

If the representative says your plan does not cover the drug, ask whether there is an exception process. Some plans will cover a GLP-1 medication if your doctor submits a letter explaining why you need it instead of cheaper alternatives. This is worth pursuing if you have tried other drugs and they did not work, or if you have a medical reason the standard drugs are unsafe for you.

What your doctor needs to do to get insurance approval

Your doctor's office will submit a prior authorization request to your insurance company. This request includes your diagnosis, your current medications, your blood sugar levels or weight (depending on what the drug is for), and an explanation of why your doctor is prescribing this specific drug. The insurance company uses this information to check whether the prescription meets their coverage rules.

If your plan has step therapy, your doctor will need to document that you have already tried the cheaper drugs your insurance prefers. This might mean providing records showing you took metformin for three months and your blood sugar did not improve, or that you tried phentermine for weight loss and it did not work. If you have not tried these drugs yet, your insurance may deny the GLP-1 prescription and require you to try them first.

Your doctor's office should tell you whether prior authorization is required before they submit the prescription. If they do not mention it, ask. Some offices handle this automatically; others expect you to call and ask them to submit the paperwork. The sooner they submit, the sooner you can start the medication.

Step therapy: when insurance makes you try cheaper drugs first

Step therapy is an insurance cost-control tool. Your plan may require you to try metformin (for diabetes) or phentermine (for weight loss) for a set period — often three to six months — before they will cover a GLP-1 drug. If you try the cheaper drug and it does not work well enough, your doctor can then request that the insurance company approve the GLP-1 medication as a step up.

This requirement frustrates patients because it delays access to a drug that might work better for them. However, it is legal and common. If your plan has step therapy, your doctor can sometimes request an exception if you have a medical reason you cannot take the cheaper drug — for example, if metformin causes severe side effects for you, or if you have already tried it in the past and it did not work.

To request an exception, your doctor writes a letter to your insurance company explaining the medical reason. This is called a prior authorization appeal or a coverage exception request. The insurance company reviews the letter and decides whether to waive the step therapy requirement. This process takes five to ten business days. There is no may provide it will succeed, but it is worth trying if the standard drug is not safe or suitable for you.

What to do if your insurance denies coverage

If your insurance company denies the prior authorization request, your doctor's office will send you a denial letter. This letter explains the reason for the denial — usually that the drug is not on the formulary, or that you did not meet step therapy requirements, or that your diagnosis does not match the plan's coverage rules.

You have two options. First, you can ask your doctor to appeal the denial. An appeal is a formal request asking the insurance company to reconsider. Your doctor writes a letter explaining why the denial was wrong — for example, that you did try the cheaper drug and it failed, or that you have a medical condition that makes the GLP-1 drug necessary. Appeals succeed roughly 30 to 40 percent of the time, depending on the plan and the reason for the original denial.

Second, you can ask your doctor whether they will prescribe the drug anyway and you will pay out of pocket. Some patients do this, especially if they can use a manufacturer discount program. Novo Nordisk (which makes Ozempic and Wegovy) and Eli Lilly (which makes Mounjaro and Zepbound) both offer copay cards that cap your monthly cost at $99 to $250, even if the full price is much higher. These programs are available only if you are paying without insurance, not if insurance is denying coverage.

How copays and out-of-pocket costs work for GLP-1 drugs

Your copay depends on which tier your insurance plan places the drug on. Tier 1 drugs have the lowest copay, usually $10 to $25. Tier 2 drugs cost more, typically $25 to $50. Tier 3 and tier 4 drugs — where GLP-1 medications usually sit — have copays of $75 to $250 or more per month. Some plans use coinsurance instead, meaning you pay a percentage of the drug's cost, such as 20 or 30 percent.

Your copay is separate from your deductible. If you have not met your deductible yet this year, you may have to pay the full price of the medication until you do. Once you have met your deductible, your copay applies. If your plan has an out-of-pocket maximum, your copay counts toward it — once you reach the maximum, the insurance company pays 100 percent of the drug's cost for the rest of the year.

If your copay is very high, ask your doctor whether a generic or lower-tier alternative exists. For diabetes, there are other newer drugs that may be on a lower tier. For weight loss, there are fewer alternatives, but your doctor can discuss what options your plan covers. You can also ask your insurance company whether they have a patient information program or whether the drug manufacturer offers a copay card.

Using manufacturer copay cards and patient information programs

Novo Nordisk and Eli Lilly both offer copay cards that reduce what you pay at the pharmacy. These cards typically cap your monthly copay at $99 to $250, regardless of what your insurance plan's copay is. To use a copay card, you must have insurance (the card does not work for uninsured patients), and you must be paying a copay — it does not work if your insurance has already denied coverage.

You get the copay card from the drug manufacturer's website or from your doctor's office. You present it at the pharmacy along with your insurance card when you fill the prescription. The card covers the difference between your insurance copay and the capped amount. This is legal and common; insurance companies expect it.

If you do not have insurance, or if your insurance denies coverage and you want to pay out of pocket, the manufacturer's patient information program may help. These programs provide the drug free or at a reduced cost to people who meet income requirements. Novo Nordisk's program is called the Novo Nordisk Patient information Program; Eli Lilly's is the Lilly Cares Foundation. Both have income limits, usually around 200 to 400 percent of the federal poverty line. You explore through the manufacturer's website.

Switching insurance plans to get better GLP-1 coverage

If your current plan does not cover GLP-1 drugs, or covers them only with a very high copay, you may be able to switch plans during open enrollment — the annual period when you can change your health insurance without a may have access to event. Open enrollment typically runs from November 15 to December 15 each year for coverage starting January 1. During this window, you can compare plans and choose one with better GLP-1 coverage.

Before you switch, check the formularies of the plans you are considering. Most insurance companies post their formularies online. Search for semaglutide or tirzepatide and note which tier it is on and what the copay would be. Also check whether the plan requires prior authorization or step therapy. A plan with a lower copay but strict step therapy requirements might not be better than your current plan.

Switching plans is worth considering only if you are certain you will use the medication for a long time. Changing plans also means changing doctors if your current doctor is not in the new plan's network, and it means new deductibles and out-of-pocket maximums. If you are only trying the medication for a few months, the hassle of switching may not be worth the savings.

Frequently Asked Questions

Does Medicare cover GLP-1 drugs for weight loss?

Medicare Part D (prescription drug coverage) does not cover GLP-1 drugs for weight loss. It covers them only for type 2 diabetes. Some Medicare Advantage plans (Part C) may cover weight loss, but this varies by plan. Call your plan to ask.

What if I change jobs and lose my insurance coverage?

If you lose insurance, you have 60 days to enroll in a new plan through the federal marketplace or your state's exchange without waiting for open enrollment. You can also continue your old plan's coverage for up to 18 months through COBRA, though you will pay the full premium yourself. During this time, you can use the manufacturer's patient information program if you cannot afford the medication out of pocket.

Can my doctor appeal if the insurance company denies coverage?

Yes. Your doctor can file a formal appeal requesting the insurance company reconsider. Include medical records showing you tried other drugs first, or explaining why you cannot take them. Appeals take five to ten business days. If the appeal is denied, you can request an external review, where an independent doctor reviews the decision — this takes longer but sometimes succeeds.

Will my copay change if I switch to a different GLP-1 drug?

Possibly. Different GLP-1 drugs may be on different tiers within the same plan. Semaglutide and tirzepatide might have different copays. Ask your insurance company about the copay for each drug before your doctor prescribes one. If one has a much lower copay, your doctor may be willing to prescribe that one instead.

What happens if I cannot afford the copay?

Ask your doctor's office about manufacturer copay cards first — these usually reduce the copay to $99 to $250 per month. If that is still too high, ask about patient information programs. If you do not may have access to for those, ask your doctor whether a lower-tier alternative exists, or whether they can request that your insurance company cover a higher percentage of the cost.